Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pap smear reimbursement

This article was originally published in The Gray Sheet

Executive Summary

House bill to increase the Medicare rate for pap smear lab work from $7.15 to $14.60 - the national average production cost of the tests - is introduced June 18 by Rep. Neil Abercrombie ( D-Hawaii). The Investment in Women's Health Act of 1998 would take effect in January 1999. "We can't afford to let economic pressures prevent medical labs from continuing pap smear work," Abercrombie states in a same day release

Latest Headlines
See All
UsernamePublicRestriction

Register

MT010233

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel